Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital
Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson's disease…The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease
Objective: The aim of this study was to verify if there would be correlations between cognitive variables (educational status, executive function, verbal fluency) and motor…Effects of a 12-week exercise program on cognition in Parkinson’s disease
Objective: To evaluate the effectiveness of a 12-week vigorous exercise program to improve primarily cognition and secondarily motor function and quality of life in patients…Transcranial sonography and cognitive dysfunction in Parkinson’s disease
Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder
Objective: The aim of this study was to investigate self-reported cognitive complaints in idiopathic REM sleep behavior disorder (iRBD) in link with the presence of…Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease
Objective: Refine understanding of the processes underpinning apathy in neurodegenerative disease, by identifying 1) objective measures to assess apathy; 2) parcellating the broad construct of…Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis
Objective: To evaluate the copper (Cu) chelation efficacy of orally administered D-penicillamine loaded nanoparticles to that of conventional D-penicillamine therapy for 90 days in Wistar…Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease
Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress…Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living
Objective: To evaluate the prevalence, interrelation and impact on health related quality of life (HRQL) and Activities of daily Living (ADL) of motor (MS) and…Staging and clinical correlates of cortical thinning in Parkinson’s disease
Objective: By using a novel disease staging model to investigate the progression and clinical associations of cortical thinning in Parkinson's disease (PD) patients. Background: The…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 117
- Next Page »